Cargando…

Circulating Tumor Cells in Esophageal Squamous Cell Carcinoma – Mini Review

Esophageal cancer has high incidence and mortality rates and a low five-year survival rate of <15% owing to its strong capabilities of invasion, relapse and metastasis. The classic view holds that metastasis and diffusion is an advanced event during cancer progression, but recent studies show tha...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shi, Yujing, Ge, Xiaolin, Ju, Mengyang, Zhang, Yumeng, Di, Xiaoke, Liang, Liang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8577339/ https://www.ncbi.nlm.nih.gov/pubmed/34764697 http://dx.doi.org/10.2147/CMAR.S337489

Ejemplares similares

Diagnostic, Prognostic, and Recurrence Monitoring Value of Plasma CYFRA21-1 and NSE Levels in Patients With Esophageal Squamous Cell Carcinoma
por: Ju, Mengyang, et al.
Publicado: (2022)

Necrotic related-lncRNAs: Prediction of prognosis and differentiation between cold and hot tumors in head and neck squamous cell carcinoma
por: Shi, Yujing, et al.
Publicado: (2023)

Irradiation induces DJ-1 secretion from esophageal squamous cell carcinoma cells to accelerate metastasis of bystander cells via a TGF-β1 positive feedback loop
por: Gu, Junjie, et al.
Publicado: (2022)

Prognostic value of circulating tumor cells in the peripheral blood of patients with esophageal squamous cell carcinoma
por: Qiao, Yuanyuan, et al.
Publicado: (2017)

Gross tumor volume is an independent prognostic factor in patients with postoperative locoregional recurrence of esophageal squamous cell carcinoma
por: Shi, Yu, et al.
Publicado: (2019)

Clinical Significance of Circulating Tumor Cells in Peripheral Blood of Patients with Esophageal Squamous Cell Carcinoma
por: Matsushita, Daisuke, et al.
Publicado: (2015)

Clinical Significance of TWIST-Positive Circulating Tumor Cells in Patients with Esophageal Squamous Cell Carcinoma
por: Lee, Hyun Jung, et al.
Publicado: (2021)

Prognostic value of modified-Gustave-Roussy Immunity Score in resectable proximal gastric cancer
por: Shi, Yujing, et al.
Publicado: (2023)

Nomogram based on circulating lymphocyte subsets for predicting radiation pneumonia in esophageal squamous cell carcinoma
por: Zhang, Xiao-zhen, et al.
Publicado: (2022)

Identification of prognostic genes and tumor-infiltrating immune cells in the tumor microenvironment of esophageal squamous cell carcinoma and esophageal adenocarcinoma
por: Huai, Qilin, et al.
Publicado: (2021)

Detection of Epithelial-Mesenchymal Transition Status of Circulating Tumor Cells in Patients with Esophageal Squamous Carcinoma
por: Han, Dingpei, et al.
Publicado: (2018)

Evaluation of the circulating level of fibroblast activation protein α for diagnosis of esophageal squamous cell carcinoma
por: Liao, Yuehua, et al.
Publicado: (2017)

Practical value of identifying circulating tumor cells to evaluate esophageal squamous cell carcinoma staging and treatment efficacy
por: Chen, Weipeng, et al.
Publicado: (2018)

Detection of Circulating Tumor Cells by Fluorescent Immunohistochemistry in Patients with Esophageal Squamous Cell Carcinoma: Potential Clinical Applications
por: Li, Shu-Ping, et al.
Publicado: (2016)

Circulating Tumor Cell Enumeration for Serial Monitoring of Treatment Outcomes for Locally Advanced Esophageal Squamous Cell Carcinoma
por: Ko, Josephine Mun Yee, et al.
Publicado: (2023)

Circulating tumor DNA dynamics analysis in a xenograft mouse model with esophageal squamous cell carcinoma
por: Terasawa, Hiroyuki, et al.
Publicado: (2021)

Assessment of durable chemoimmunotherapy response via circulating tumor DNA in advanced esophageal squamous cell carcinoma
por: Yang, Dongyang, et al.
Publicado: (2022)

Tumor-Associated Microbiota in Esophageal Squamous Cell Carcinoma
por: Yang, Weixiong, et al.
Publicado: (2021)

Circulating Tumor Cell Analyses in Patients With Esophageal Squamous Cell Carcinoma Using Epithelial Marker-Dependent and -Independent Approaches
por: Li, Hao, et al.
Publicado: (2015)

The tumor suppressive role of NUMB isoform 1 in esophageal squamous cell carcinoma
por: Hong, Junmou, et al.
Publicado: (2014)

Post-radiation circulating tumor DNA as a prognostic factor in locally advanced esophageal squamous cell carcinoma
por: Jia, Ru, et al.
Publicado: (2021)

Plasma Circulating Tumor DNA Sequencing Predicts Minimal Residual Disease in Resectable Esophageal Squamous Cell Carcinoma
por: Liu, Tao, et al.
Publicado: (2021)

Tumor Initiating Cells in Esophageal Squamous Cell Carcinomas Express High Levels of CD44
por: Zhao, Jiang-Sha, et al.
Publicado: (2011)

Clinical significance of tumor cells in the peripheral blood of patients with esophageal squamous cell carcinoma
por: Han, Lu, et al.
Publicado: (2019)

DNAJB6 Promotes Ferroptosis in Esophageal Squamous Cell Carcinoma
por: Jiang, Bin, et al.
Publicado: (2019)

Tumor xenograft animal models for esophageal squamous cell carcinoma
por: Lee, Nikki P., et al.
Publicado: (2018)

Biological Significance of Tumor Heterogeneity in Esophageal Squamous Cell Carcinoma
por: Lin, Lehang, et al.
Publicado: (2019)

Clinical value of folate receptor-positive circulating tumor cells in patients with esophageal squamous cell carcinomas: a retrospective study
por: Zhou, Qiang, et al.
Publicado: (2023)

Epidemiology, etiology, and prevention of esophageal squamous cell carcinoma in China
por: Liang, He, et al.
Publicado: (2017)

Lymphopenia and Radiation Dose to Circulating Lymphocytes With Neoadjuvant Chemoradiation in Esophageal Squamous Cell Carcinoma
por: So, Tsz Him, et al.
Publicado: (2020)

Circulating microRNA/isomiRs as novel biomarkers of esophageal squamous cell carcinoma
por: Ibuki, Yuta, et al.
Publicado: (2020)

A clinical prognostic model for patients with esophageal squamous cell carcinoma based on circulating tumor DNA mutation features
por: Liu, Tao, et al.
Publicado: (2023)

Trastuzumab anti-tumor efficacy in patient-derived esophageal squamous cell carcinoma xenograft (PDECX) mouse models
por: Wu, Xianhua, et al.
Publicado: (2012)

Circulating tumor cells in oral squamous cell carcinoma-an enigma or reality?
por: Anitha, N., et al.
Publicado: (2015)

Genomic and molecular characterization of esophageal squamous cell carcinoma
por: Lin, De-Chen, et al.
Publicado: (2014)

Immunotherapy for Esophageal Squamous Cell Carcinoma
por: Kojima, Takashi, et al.
Publicado: (2017)

Pharmaceutical inhibition of AXL suppresses tumor growth and invasion of esophageal squamous cell carcinoma
por: Han, Sha, et al.
Publicado: (2020)

Circulating Tumor DNA in Head and Neck Squamous Cell Carcinoma
por: Brandt, Anna, et al.
Publicado: (2023)

FTO mediated ERBB2 demethylation promotes tumor progression in esophageal squamous cell carcinoma cells
por: Zhao, Fangfang, et al.
Publicado: (2022)

Subtype-Based Analysis of Cell-in-Cell Structures in Esophageal Squamous Cell Carcinoma
por: Wang, Yuqi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_72nuslnjgk9toump1ouicvor08